BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dong JJ, Ying L, Shi KQ. Expression of the Wnt ligands gene family and its relationship to prognosis in hepatocellular carcinoma. Cancer Cell Int 2019;19:34. [PMID: 30814912 DOI: 10.1186/s12935-019-0743-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Selvaggi F, Catalano T, Cotellese R, Aceto GM. Targeting Wnt/β-Catenin Pathways in Primary Liver Tumours: From Microenvironment Signaling to Therapeutic Agents. Cancers 2022;14:1912. [DOI: 10.3390/cancers14081912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Arjmand B, Hamidpour SK, Alavi-moghadam S, Yavari H, Shahbazbadr A, Tavirani MR, Gilany K, Larijani B. Molecular Docking as a Therapeutic Approach for Targeting Cancer Stem Cell Metabolic Processes. Front Pharmacol 2022;13:768556. [DOI: 10.3389/fphar.2022.768556] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Hassan SS, Maqsood N, Wang Q, Tao S, Sadaf S. A panel of epigenetically dysregulated Wnt signaling pathway genes for non-invasive diagnosis of pediatric acute lymphoblastic leukemia. Cancer Biomark 2021. [PMID: 34334378 DOI: 10.3233/CBM-200814] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Suthon S, Perkins RS, Bryja V, Miranda-Carboni GA, Krum SA. WNT5B in Physiology and Disease. Front Cell Dev Biol 2021;9:667581. [PMID: 34017835 DOI: 10.3389/fcell.2021.667581] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
5 Ni CJ, Qin XS, Huang ZS. Role of Wnt/β-catenin signaling pathway in occurrence and development of hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2021; 29(4): 190-196 [DOI: 10.11569/wcjd.v29.i4.190] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Li H, Xie L, Wang Q, Dang Y, Sun X, Zhang L, Han Y, Yan Z, Dong H, Zheng H, Li Y, Zhu W, Guo X. OSmfs: An Online Interactive Tool to Evaluate Prognostic Markers for Myxofibrosarcoma. Genes (Basel) 2020;11:E1523. [PMID: 33352742 DOI: 10.3390/genes11121523] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Hui J, Wang C, Miao Y, Liu R, Xu J. The pancancer landscape of Wnt family expression reveals potential biomarkers in urinary system tumors. Cancer Gene Ther 2021;28:1035-45. [PMID: 33311568 DOI: 10.1038/s41417-020-00273-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Norollahi SE, Hamidian SMT, Vahidi S, Babaei K, Samadani AA. Modifications of WNT signaling pathway genes including WNT1, KLF5 and WNT16 in colorectal cancer. Gene Reports 2020;20:100733. [DOI: 10.1016/j.genrep.2020.100733] [Reference Citation Analysis]
9 Wang W, Zhu G, Lai S, Guo Y, Yin X, Chen D, Wen L. Angiogenic Factor with G Patch and FHA Domains 1 (AGGF1) Acts as Diagnostic Biomarker and Adverse Prognostic Factor of Hepatocellular Carcinoma (HCC): Evidence from Bioinformatic Analysis. Med Sci Monit 2020;26:e919896. [PMID: 32090983 DOI: 10.12659/MSM.919896] [Reference Citation Analysis]
10 Issa F. Research Highlights. Transplantation 2019;103:855-856. [DOI: 10.1097/tp.0000000000002713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]